Safety and efficacy of Gliadel wafers for newly diagnosed and recurrent glioblastoma
Safety and efficacy of Gliadel wafers for newly diagnosed and recurrent glioblastoma
About this item
Full title
Author / Creator
Publisher
Vienna: Springer Vienna
Journal title
Language
English
Formats
Publication information
Publisher
Vienna: Springer Vienna
Subjects
More information
Scope and Contents
Contents
Background
Combining Gliadel wafers and radiochemotherapy with TMZ may carry the risk of increased adverse events (AE). We analyzed the efficacy and safety in patients with glioblastoma who underwent multimodal treatment with implantation of Gliadel wafers.
Methods
One hundred sixty-five consecutive patients with newly diagnosed (77 patien...
Alternative Titles
Full title
Safety and efficacy of Gliadel wafers for newly diagnosed and recurrent glioblastoma
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1069196776
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1069196776
Other Identifiers
ISSN
0001-6268,0942-0940
E-ISSN
0942-0940
DOI
10.1007/s00701-012-1413-2